Healthcare • NASDAQ
According to Zyberno, Addus HomeCare Corp (ADUS) shows Underestimated Growth — GOOD BUSINESS (68/100) with a Brina Gap of +23.5% showing underestimated forward growth, but no margin of safety at -28.4%.
According to Zyberno's DCF model, Addus HomeCare Corp (ADUS) trades at $115.55 against an estimated intrinsic value per share of $89.99 — a -28.4% Margin of Safety based on Owner Earnings of $137.38M TTM, projected at -0.2% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of +23.5% strengthens the case: based on the company's ROIC (9.6%) and reinvestment rate (315.2%), the business can fundamentally grow at 30.4% — but the current enterprise value implies the market expects 6.9%. This places ADUS in the Underestimated Growth quadrant of the Brina Matrix, where growth is underestimated but no margin of safety on existing cash. Zyberno's model translates this into a 5-year expected return of -5.1% annually.
Over the trailing twelve months, ADUS generated $137.38M in Owner Earnings. Capital was deployed as follows: $7.55M invested in capital expenditures. Reinvestment rate: 315.2%. Owner Earnings have declined at 0.2% annually over the trailing five years using log-linear regression.